A randomized, multicenter phase III clinical trial comparing gemcitabine and cisplatin with 5-fluorouracil and cisplatin in the treatment of recurrent or metastatic nasopharyngeal carcinoma
Journal of Clinical Oncology, 2017.
TPS6098 Background: Nasopharyngeal carcinoma (NPC) is highly sensitive to both radiotherapy and chemotherapy. Nowadays, the regimen of 5-Fluorouracil plus cisplatin (FP) is widely used in recurrent or metastatic (R/M) NPC patients, but the response period is usually short and the adverse reaction is frequent and badly tolerant. Several sm...More
Full Text (Upload PDF)